4.4 Article

Alcohol and other substance use after bariatric surgery: prospective evidence from a US multicenter cohort study

Journal

SURGERY FOR OBESITY AND RELATED DISEASES
Volume 13, Issue 8, Pages 1392-1404

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.soard.2017.03.021

Keywords

Roux-en -Y gastric bypass; Gastric band; Obese; Substance use; Disorder; Addiction: Abuse; Treatment

Categories

Funding

  1. NCATS NIH HHS [UL1 TR002384] Funding Source: Medline
  2. NCRR NIH HHS [M01 RR000037, UL1 RR024153, UL1 RR024996] Funding Source: Medline
  3. NIDDK NIH HHS [U01 DK066568, U01 DK066667, U01 DK066555, U01 DK066557, U01 DK066471, U01 DK066526, U01 DK066585] Funding Source: Medline

Ask authors/readers for more resources

Background: Empirical evidence suggests Roux-en-Y gastric bypass (RYGB) increases risk of developing alcohol use disorder (AUD). However, prospective assessment of substance use disorders (SUD) after bariatric surgery is limited. Objective: To report SUD-related outcomes after RYGB and laparoscopic adjustable gastric banding (LAGB). To identify factors associated with incident SUD-related outcomes. Setting: 10 U.S. hospitals Methods: The Longitudinal Assessment of Bariatric Surgery-2 is a prospective cohort study. Participants self-reported past-year AUD symptoms (determined by the Alcohol Use Disorders Identification Test), illicit drug use (cocaine, hallucinogens, inhalants, phencyclidine, amphetamines, or marijuana), and SUD treatment (counseling or hospitalization for alcohol or drugs) presurgery and annually postsurgery for up to 7 years through January 2015. Results: Of 2348 participants who underwent RYGB or LAGB, 2003 completed baseline and followup assessments (79.2% women, baseline median age: 47 years, median body mass index 45.6). The year-5 cumulative incidence of postsurgery onset AUD symptoms, illicit drug use, and SUD treatment were 20.8% (95% confidence interval (CI): 18.5-23.3), 7.5% (95% CI: 6.1-9.1), and 3.5% (95% CI: 2.6-4.8), respectively, post-RYGB, and 11.3% (95% CI: 8.5-14.9), 4.9% (95% CI: 3.1-7.6), and.9% (95% CI:.4-2.5) post-LAGB. Undergoing RYGB versus LAGB was associated with higher risk of incident AUD symptoms (adjusted hazard ratio or AHR = 2.08 [95% CI: 1.51-2.851), illicit drug use (AHR = 1.76 [95% CI: 1.07-2.90]) and SUD treatment (AHR = 3.56 [95% CI: 1.26-10.07]). Conclusions: Undergoing RYGB versus LAGB was associated with twice the risk of incident AUD symptoms. One-fifth of participants reported incident AUD symptoms within 5 years post-RYGB. AUD education, screening, evaluation, and treatment referral should be incorporated in pre-and postoperative care. (Surg Obes Relat Dis 2017;13:1392-1404.) (C) 2017 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available